These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 26001262)

  • 1. A prospective clinical study to evaluate the safety and performance of wireless localization of nonpalpable breast lesions using radiofrequency identification technology.
    Dauphine C; Reicher JJ; Reicher MA; Gondusky C; Khalkhali I; Kim M
    AJR Am J Roentgenol; 2015 Jun; 204(6):W720-3. PubMed ID: 26001262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retrospective Review of Preoperative Radiofrequency Tag Localization of Breast Lesions in 848 Patients.
    Lamb LR; Gilman L; Specht M; D'Alessandro HA; Miles RC; Lehman CD
    AJR Am J Roentgenol; 2021 Sep; 217(3):605-612. PubMed ID: 33084384
    [No Abstract]   [Full Text] [Related]  

  • 3. A multicenter prospective cohort study to evaluate feasibility of radio-frequency identification surgical guidance for nonpalpable breast lesions: design and rationale of the RFID Localizer 1 Trial.
    den Dekker BM; Christenhusz A; van Dalen T; Jongen LM; van der Schaaf MC; Dassen AE; Pijnappel RM
    BMC Cancer; 2022 Mar; 22(1):305. PubMed ID: 35317766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wireless Breast Localization Using Radio-frequency Identification Tags: The First Reported European Experience in Breast Cancer.
    Wazir U; Tayeh S; Perry N; Michell M; Malhotra A; Mokbel K
    In Vivo; 2020; 34(1):233-238. PubMed ID: 31882483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiofrequency as a method of localizing impalpable breast lesions.
    Malik M; Brookes P; Kasana MI; Tromans L; Audrey Chew WY; Green MJ
    Surgeon; 2024 Oct; 22(5):296-300. PubMed ID: 39179450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RFID trial: localization of non-palpable breast lesions using radiofrequency identification tags or wire.
    Veyssiere H; Dressaire M; Pete R; Pinard C; Molnar I; Abrial C; Ginzac A; Durando X; Tekath M
    BMC Cancer; 2023 Jul; 23(1):679. PubMed ID: 37468859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiofrequency localization of nonpalpable breast cancer in a multicentre prospective cohort study: feasibility, clinical acceptability, and safety.
    Christenhusz A; den Dekker BM; van Dalen T; Jongen L; van der Schaaf MC; Alic L; Ten Haken B; Pijnappel RM; Dassen AE
    Breast Cancer Res Treat; 2023 Aug; 201(1):67-75. PubMed ID: 37322358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioguided localization of nonpalpable breast cancer lesions: randomized comparison with wire localization in patients undergoing conservative surgery and sentinel node biopsy.
    Mariscal Martínez A; Solà M; de Tudela AP; Julián JF; Fraile M; Vizcaya S; Fernández J
    AJR Am J Roentgenol; 2009 Oct; 193(4):1001-9. PubMed ID: 19770322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The LOCalizer Radiofrequency Identification System: An Effective New Technology for Localizing Non-Palpable Breast Lesions for Surgery.
    Cullinane CM; Byrne J; Akmenkalne L; O' Leary DP; Connors AM; Corrigan MA; Redmond HP; Kelly L; O' Sullivan MJ
    Surg Innov; 2021 Aug; 28(4):473-478. PubMed ID: 33085567
    [No Abstract]   [Full Text] [Related]  

  • 10. Microchipping the breast: an effective new technology for localizing non-palpable breast lesions for surgery.
    DiNome ML; Kusske AM; Attai DJ; Fischer CP; Hoyt AC
    Breast Cancer Res Treat; 2019 May; 175(1):165-170. PubMed ID: 30689105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiofrequency identification tag localization is comparable to wire localization for non-palpable breast lesions.
    McGugin C; Spivey T; Coopey S; Smith B; Kelly B; Gadd M; Hughes K; Dontchos B; Specht M
    Breast Cancer Res Treat; 2019 Oct; 177(3):735-739. PubMed ID: 31302856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Prospective, Single Arm, Multi-site, Clinical Evaluation of a Nonradioactive Surgical Guidance Technology for the Location of Nonpalpable Breast Lesions during Excision.
    Cox CE; Russell S; Prowler V; Carter E; Beard A; Mehindru A; Blumencranz P; Allen K; Portillo M; Whitworth P; Funk K; Barone J; Norton D; Schroeder J; Police A; Lin E; Combs F; Schnabel F; Toth H; Lee J; Anglin B; Nguyen M; Canavan L; Laidley A; Warden MJ; Prati R; King J; Shivers SC
    Ann Surg Oncol; 2016 Oct; 23(10):3168-74. PubMed ID: 27469121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraoperative ultrasound localization of nonpalpable breast cancers.
    Ngô C; Pollet AG; Laperrelle J; Ackerman G; Gomme S; Thibault F; Fourchotte V; Salmon RJ
    Ann Surg Oncol; 2007 Sep; 14(9):2485-9. PubMed ID: 17541694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First Reported Use of the Faxitron LOCalizer™ Radiofrequency Identification (RFID) System in Europe - A Feasibility Trial, Surgical Guide and Review for Non-palpable Breast Lesions.
    Malter W; Holtschmidt J; Thangarajah F; Mallmann P; Krug B; Warm M; Eichler C
    In Vivo; 2019; 33(5):1559-1564. PubMed ID: 31471405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Wire and Beyond: Recent Advances in Breast Imaging Preoperative Needle Localization.
    Kapoor MM; Patel MM; Scoggins ME
    Radiographics; 2019; 39(7):1886-1906. PubMed ID: 31560614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of radioactive seed localization with I-125 prior to lumpectomy and/or excisional biopsy.
    Sung JS; King V; Thornton CM; Brooks JD; Fry CW; El-Tamer M; Dauer LT; Brogi E; St Germain JM; Morris EA
    Eur J Radiol; 2013 Sep; 82(9):1453-7. PubMed ID: 23684386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [MRI-controlled preoperative wire marking of uncertain breast lesions].
    Langen HJ; Kugel H; Grewe S; Landwehr P; Schmidt T; Schäfer R; Mallmann P; Lackner K
    Rofo; 2000 Sep; 172(9):764-9. PubMed ID: 11079090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a Ferromagnetic Marker Technology for Intraoperative Localization of Nonpalpable Breast Lesions.
    Nicolae A; Dillon J; Semple M; Hong NL; Ravi A
    AJR Am J Roentgenol; 2019 Apr; 212(4):727-733. PubMed ID: 30673343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioguided occult lesion localisation using iodine-125 seeds ('ROLLIS') for removal of impalpable breast lesions: First Australian experience.
    Taylor DB; Bourke AG; Westcott E; Burrage J; Latham B; Riley P; Ballal H; Kamyab R; Frost F; Dissanayake D; Landman J; Phillips M; Saunders C
    J Med Imaging Radiat Oncol; 2015 Aug; 59(4):411-420. PubMed ID: 25871837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of methylene blue dye for localization biopsy of nonpalpable breast lesions.
    Tang J; Wang X; Wu YP; Wang X; Lian ZQ; Fu JH; Yang MT
    Ai Zheng; 2009 Jan; 28(1):79-81. PubMed ID: 19448424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.